BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4270058)

  • 1. Specific antiserum to rheumatoid arthritis amyloid and its cross reactivity with various amyloid preparation.
    Shapira E; Yogev R; Pras M; Russell A
    Isr J Med Sci; 1973 Jul; 9(7):868-74. PubMed ID: 4270058
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum immunoglobulin E levels in patients with neoplastic disease.
    Waldmann TA; Bull JM; Bruce RM; Broder S; Jost MC; Balestra ST; Suer ME
    J Immunol; 1974 Jul; 113(1):379-86. PubMed ID: 4208923
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunoglobulin biosynthesis in myeloma-associated and casein- and endotoxin-induced murine amyloidosis.
    Baumal R; Ackermann A; Wilson B
    J Immunol; 1975 Jun; 114(6):1785-91. PubMed ID: 1092761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigenicity and cross-reactivity of denatured fibril proteins of primary, secondary, and myeloma associated amyloids.
    Benson MD; Skinner M; Cohen AS
    J Lab Clin Med; 1975 Apr; 85(4):650-9. PubMed ID: 47375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological characterization of amyloid fibrils in tissue sections.
    Husby G; Natvig JB
    Clin Exp Immunol; 1972 Jul; 11(3):357-66. PubMed ID: 4114473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloidosis in rheumatoid arthritis.
    Husby G
    Ann Clin Res; 1975 Jun; 7(3):154-67. PubMed ID: 1103711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [On the problem of the antigenic composition of amyloid].
    Shekhonin BV
    Arkh Patol; 1966; 28(12):43-8. PubMed ID: 4177885
    [No Abstract]   [Full Text] [Related]  

  • 8. [Bence Jones protein and amyloid. Studies on the relationship between naturally occurring human anti-Bence Jones protein antibodies and Bence Jones protein with amyloid].
    Sellin D; Haferkamp O
    Z Gesamte Exp Med Einschl Exp Chir; 1968; 147(3):173-89. PubMed ID: 4876308
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization of a conjugated anti-serum for the detection of Treponema pallidum by the direct fluorescent antibody technique.
    See IM
    Health Lab Sci; 1972 Jul; 9(3):197-202. PubMed ID: 4625661
    [No Abstract]   [Full Text] [Related]  

  • 10. Characterization of antiserum against myeloma cells.
    Cawley LP; Goodwin WL; Minard BJ
    Cancer Res; 1973 Jan; 33(1):17-22. PubMed ID: 4629871
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunofluorescence studies in human leukemia.
    Bates HA; Bankole RO; Swaim WR
    Blood; 1969 Oct; 34(4):431-40. PubMed ID: 4309683
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunohistochemical identification of amyloid deposits.
    Brozman M; Grígel M
    Acta Histochem; 1970; 35(1):200-2. PubMed ID: 4985775
    [No Abstract]   [Full Text] [Related]  

  • 13. Amyloid. IV. Is human amyloid immunogenic?
    Sri Ram J; DeLellis RA; Glenner GG
    Int Arch Allergy Appl Immunol; 1968; 34(3):269-82. PubMed ID: 4176084
    [No Abstract]   [Full Text] [Related]  

  • 14. Hidden rheumatoid factors reacting with "non a" and other antigens of native autologous IgG.
    Gaarder PI; Natvig JB
    J Immunol; 1970 Oct; 105(4):928-37. PubMed ID: 4990439
    [No Abstract]   [Full Text] [Related]  

  • 15. Amyloid in localized cutaneous amyloidosis: immunofluorescence studies with anti-keratin antiserum especially concerning the difference between systemic and localized cutaneous amyloidosis.
    Masu S; Hosokawa M; Seiji M
    Acta Derm Venereol; 1981; 61(5):381-4. PubMed ID: 6172924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid fibril protein subunit, "protein AS": distribution in tissue and serum in different clinical types of amyloidosis including that associated with myelomatosis and Waldenström's macroglobulinamia.
    Husby G; Sletten K; Michaelsen TE; Natvig JB
    Scand J Immunol; 1973; 2(4):395-404. PubMed ID: 4203674
    [No Abstract]   [Full Text] [Related]  

  • 17. A human IgG myeloma protein with anti- 2 macroglobulin antibody activity.
    Seligmann M; Sassy C; Chevalier A
    J Immunol; 1973 Jan; 110(1):85-90. PubMed ID: 4631075
    [No Abstract]   [Full Text] [Related]  

  • 18. "A" protein of amyloidosis. Isolation of a cross-reacting component from serum by affinity chromatography.
    Benson MD; Skinner M; Lian J; Cohen AS
    Arthritis Rheum; 1975; 18(4):315-22. PubMed ID: 50844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variable reactivity of antinuclear immunoglobulins with cell nuclei of various origin and quality.
    Zitńan D; Cebecauer L
    J Hyg Epidemiol Microbiol Immunol; 1970; 14(3):303-12. PubMed ID: 4921006
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunochemical studies on the nature of the serum component (SAA) related to secondary amyloidosis.
    Ignaczak TF; Sipe JD; Linke FP; Glenner GG
    J Lab Clin Med; 1977 May; 89(5):1092-1104. PubMed ID: 404372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.